{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:31:11Z","timestamp":1791117071530,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1532\/ijh97.05017","type":"journal-article","created":{"date-parts":[[2005,6,16]],"date-time":"2005-06-16T19:01:52Z","timestamp":1118948512000},"page":"417-420","source":"Crossref","is-referenced-by-count":7,"title":["Blastic Transformation after Splenectomy in a Patient with Nonvillous Splenic Marginal Zone Lymphoma with p53 Overexpression: A Case Report"],"prefix":"10.1007","volume":"81","author":[{"given":"Yasutaka","family":"Kakinoki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroharu","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Tokusashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"E00001","unstructured":"Isaacson PG, Piris MA, Catovski D, et al. Splenic marginal zone lymphoma. In Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:135-137."},{"key":"E00002","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/1097-0142(20010115)91:2<294::AID-CNCR1001>3.0.CO;2-W","author":"Franco, V","year":"2001","unstructured":"Franco V, Florena AM, Stella M, et al. Splenectomy influences bone marrow infiltration in patients with splenic marginal zone cell lymphoma with or without villous lymphocytes. Cancer. 2001;91:294-301.","journal-title":"Cancer"},{"key":"E00003","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood.V87.8.3351.bloodjournal8783351","volume":"87","author":"Hernandez, L","year":"1996","unstructured":"Hernandez L, Fest T, Cazorla M, et al. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood. 1996;87:3351-3359.","journal-title":"Blood"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood.V90.10.4078","volume":"90","author":"Koduru, PRK","year":"1997","unstructured":"Koduru PRK, Raju K, Vadmal V, et al. Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma. Blood. 1997;90:4078-4091.","journal-title":"Blood"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<718::AID-CNCR22>3.0.CO;2-Y","volume":"85","author":"Chen, P","year":"1999","unstructured":"Chen P-M, Chiou T-J, Hsieh R-K, et al. p53 gene mutations and rearrangements in non-Hodgkin's lymphoma. Cancer. 1999;85: 718-724.","journal-title":"Cancer"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","volume":"100","author":"Chacon, JI","year":"2002","unstructured":"Chacon JI, Mollejo M, Munoz E, et al. Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood. 2002;100:1648-1654.","journal-title":"Blood"},{"key":"E00007","first-page":"88","volume":"169","author":"O'Reilly, RA","year":"1998","unstructured":"O'Reilly RA. Splenomegaly in 2,505 patients at a large university medical center from 1913 to 1995: 1963 to 1995: 449 patients. West J Med. 1998;169:88-97.","journal-title":"West J Med"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.1997.3973215.x","volume":"99","author":"Baldini, L","year":"1997","unstructured":"Baldini L, Guffanti A, Cro L, et al. Poor prognosis in non-villous splenic marginal zone cell lymphoma is associated with p53 mutations. Br J Haematol. 1997;99:375-378.","journal-title":"Br J Haematol"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1182\/blood.V97.11.3552","volume":"97","author":"Gruszka-Westwood, AM","year":"2001","unstructured":"Gruszka-Westwood AM, Hamoudi RA, Matutes E, Tuset E, Catovsky D. p53 abnormalities in splenic lymphoma with villous lymphocytes. Blood. 2001;97:3552-3558.","journal-title":"Blood"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.8023157","volume":"265","author":"Cho, Y","year":"1994","unstructured":"Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science. 1994;265:346-355.","journal-title":"Science"}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.05017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T19:40:04Z","timestamp":1586288404000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.05017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,1]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,6,1]]}},"alternative-id":["XX9UT234PH5W63VG"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.05017","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6,1]]}}}